Page last updated: 2024-12-05
n-ethyl-4-toluenesulfonamide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 6637 |
| CHEMBL ID | 1492809 |
| SCHEMBL ID | 126985 |
| MeSH ID | M0220694 |
Synonyms (63)
| Synonym |
|---|
| AKOS000431178 |
| NCIOPEN2_000527 |
| 80-39-7 |
| p-toluenesulfonamide, n-ethyl- |
| n-ethyl-p-tolylsulfonamide |
| santicizer 3 |
| nsc68803 |
| n-ethyl-p-toluenesulfonamide |
| nsc-68803 |
| n-tosylethylamine |
| p-tolueneethylsulfonamide |
| n-ethyl-p-methylbenzenesulfonamide |
| p-toluenesulfonyl-n-ethylamide |
| benzenesulfonamide, n-ethyl-4-methyl- |
| NCGC00091206-01 |
| n-ethyl-4-methylbenzenesulfonamide |
| ccris 6037 |
| nsc 68803 |
| n-ethyl-4-toluenesulfonamide |
| einecs 201-275-1 |
| n-ethyltoluene-4-sulphonamide |
| ethyl tosylamide |
| n-ethyl-p-toluenesulfonamide, 98% |
| n-ethyl-4-methyl benzenesulfonamide |
| STK416319 |
| E0674 |
| HMS1661F02 |
| ohpzpbndovqjmh-uhfffaoysa- |
| inchi=1/c9h13no2s/c1-3-10-13(11,12)9-6-4-8(2)5-7-9/h4-7,10h,3h2,1-2h3 |
| n-ethyl-4-methyl-benzenesulfonamide |
| A839926 |
| A9951 |
| NCGC00091206-02 |
| tox21_200366 |
| dtxcid405310 |
| dtxsid5025310 , |
| NCGC00257920-01 |
| cas-80-39-7 |
| unii-992s798sjb |
| 992s798sjb , |
| FT-0631358 |
| ethyl p-toluenesulfonamide |
| p-toluene-n-ethylsulfonamide |
| 1321-54-6 |
| ethyl-p-toluenesulfonamide |
| CHEMBL1492809 |
| n-ethyl(4-methyl phenyl) sulfonamide |
| SCHEMBL126985 |
| n-ethyl-4-methylbenzene-1-sulfonamide |
| W-104236 |
| cbz-d-phenylalaninemethylester |
| n-ethyl-p-toluene sulfonamide |
| unipex 108 |
| 4-toluenesulfonamide, n-ethyl- |
| ethyl toluenesulfonamide |
| Z45528338 |
| n-ethyl-4-toluene sulfonamide |
| AS-14234 |
| EN300-15862 |
| Q27272165 |
| CS-0151957 |
| n-ethyl-4-methylbenzenesulfonamide 100 microg/ml in acetonitrile |
| n-ptsa |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Protein Targets (4)
Potency Measurements
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| acetylcholinesterase | Homo sapiens (human) | Potency | 73.0113 | 0.0025 | 41.7960 | 15,848.9004 | AID1347395 |
| aldehyde dehydrogenase 1 family, member A1 | Homo sapiens (human) | Potency | 39.8107 | 0.0112 | 12.4002 | 100.0000 | AID1030 |
| progesterone receptor | Homo sapiens (human) | Potency | 31.4810 | 0.0004 | 17.9460 | 75.1148 | AID1346795 |
| retinoic acid nuclear receptor alpha variant 1 | Homo sapiens (human) | Potency | 70.4772 | 0.0030 | 41.6115 | 22,387.1992 | AID1159552 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
Bioassays (5)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| AID1159607 | Screen for inhibitors of RMI FANCM (MM2) intereaction | 2016 | Journal of biomolecular screening, Jul, Volume: 21, Issue:6 | A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | |||
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.69
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.69) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 1 (14.29%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (85.71%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||